Perceptive Advisors - CASI PHARMACEUTICALS INC ownership

CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 56 filers reported holding CASI PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of CASI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$204,000
-43.3%
43,6820.0%0.01%
-44.4%
Q2 2018$360,000
+97.8%
43,6820.0%0.01%
+80.0%
Q1 2018$182,000
-33.1%
43,682
-47.8%
0.01%
-44.4%
Q4 2017$272,00083,6820.01%
Other shareholders
CASI PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Wellington Shields & Co., LLC 951,064$7,827,0004.06%
Wellington Shields Capital Management, LLC 855,056$7,037,0001.16%
Manatuck Hill Partners, LLC 15,090$124,0000.05%
Moors & Cabot, Inc. 22,935$187,0000.02%
Perceptive Advisors 43,682$360,0000.01%
ROYCE & ASSOCIATES LP 120,000$988,0000.01%
ALPS ADVISORS INC 125,015$1,029,0000.01%
MetLife Investment Management, LLC 26,316$217,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 136,518$1,124,0000.00%
Private Advisor Group, LLC 15,001$122,0000.00%
View complete list of CASI PHARMACEUTICALS INC shareholders